| Market Cap | 10.9B |
| Market Cap (USD) | $1.5B |
| P/E Ratio | - |
| P/B Ratio | - |
| EPS | -0.21 |
| Dividend Yield | - |
| D/E Ratio | 0.45 |
| Current Ratio | 1.30 |
| Market Segment | SME |
| Currency | CNY |
Business Overview
Zhejiang Hisoar Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceutical products and dyes in China and internationally. The company offers antibiotics, cardiovascular, hypoglycemic, fine chemicals, formulations, intermediates, and other products. It also provides dyestuff, and intermediates of dyestuff and pigment; and manufactures environmental protection related equipment, medical chemical supplies and appliances, and other chemical intermediates. The company was founded in 1966 and is based in Taizhou, China.
Key Financial Metrics
Profitability
Returns & Efficiency
Financial Health
| Industry | C27医药制造业 |
| Market Segment | SME |
| Currency | CNY |
| Fiscal Year | 2024 |
Stock Chart
Full charting with technical indicators, candlestick, line charts, and more.
Company Profile
| Company Name | 海翔药业 |
| Ticker | 002099 |
| Exchange | SZSE |
| Sector | 证监会行业分类 |
| Industry | C27医药制造业 |
| Market Segment | SME |
| Fiscal Year | 2024 |
| Currency | CNY |
| Market Cap | 10.9B |
| Market Cap (USD) | $1.5B |
| Revenue | 1.9B |
| Net Income | -334.0M |
| P/E Ratio | - |
| EPS | -0.21 |
| Net Margin | -17.2% |
| ROE | -6.5% |
| Dividend Yield | - |
Zhejiang Hisoar Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceutical products and dyes in China and internationally. The company offers antibiotics, cardiovascular, hypoglycemic, fine chemicals, formulations, intermediates, and other products. It also provides dyestuff, and intermediates of dyestuff and pigment; and manufactures environmental protection related equipment, medical chemical supplies and appliances, and other chemical intermediates. The company was founded in 1966 and is based in Taizhou, China.